Nyxoah NYXH
NASDAQ NYXH
$1.40 -0.08 (-5.41%)
At close: Sep 22, 2026 · 4:00 PM EDT

Nyxoah (NYXH) Cash from Financing Activities (2021 - 2026)

Nyxoah (NYXH) posted Cash from Financing Activities of $103.0 million for Q2 2026, up 21887.16% on a QoQ basis from $468298.3 in Q1 2026, and up 4808.19% year-over-year from $2.1 million in Q2 2025.

Analysis

Nyxoah (NYXH) Cash from Financing Activities (2021 - 2026) Analysis & Trends

Nyxoah has reported Cash from Financing Activities for 6 years, with the latest figure at $103.0 million in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 4808.19% year-over-year to $103.0 million in Q2 2026; TTM through Jun 2026 was $149.2 million, a 344.88% increase from a year earlier, with the FY2025 full-year figure at $43.1 million, down 48.63% from the prior year.
  • Cash from Financing Activities was $103.0 million for Q2 2026 at Nyxoah, up from $468298.3 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $103.0 million in Q2 2026, with the low at -$2.2 million in Q2 2025.
  • Average Cash from Financing Activities over 5 years is $13.8 million, with a median of $317202.1 recorded in 2022.
  • The largest YoY upside for Cash from Financing Activities was 9839.52% in 2023 against a maximum downside of 245.75% in 2023.
  • Over 5 years, Cash from Financing Activities stood at -$223434.2 in 2022, then sank by 245.75% to -$772524.9 in 2023, then jumped by 3333.35% to $25.0 million in 2024, then soared by 84.61% to $46.1 million in 2025, then surged by 123.29% to $103.0 million in 2026.
  • The last three Cash from Financing Activities figures came in at $103.0 million (Q2 2026), $468298.3 (Q1 2026), and $46.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn -300,000.00
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn -607.30 Mn
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn -263.16 Mn
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn -510.00 Mn
10 Nyxoah 63.68 Mn -49.98 Mn 5.33 Mn 103.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.97 Mn
Mar 31, 2026 468,298.26
Dec 31, 2025 46.11 Mn
Sep 30, 2025 -356,561.80
Jun 30, 2025 -2.19 Mn
Mar 31, 2025 767,875.64
Dec 31, 2024 24.98 Mn
Sep 30, 2024 9.98 Mn
Jun 30, 2024 48.71 Mn
Mar 31, 2024 -274,849.53
Dec 31, 2023 -772,524.85
Sep 30, 2023 -239,489.90
Jun 30, 2023 2.63 Mn
Mar 31, 2023 16.51 Mn
Dec 31, 2022 -223,434.17
Sep 30, 2022 -402,301.46
Jun 30, 2022 -547,400.08
Mar 31, 2022 166,105.98
Dec 31, 2021 -330,607.60
Sep 30, 2021 88.15 Mn
API Access

Nyxoah Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=NYXH&period=max&api_key=YOUR_API_KEY